Michael Freeman Archives
Team’s potential lung cancer therapy lands award from SBIR
Sep. 27, 2018—A potential cancer drug aimed at enhancing the effectiveness of ionizing radiation in lung cancer patients is a step closer to development with funding support from the Small Business Innovation Research (SBIR) program.
Radiation and pulmonary fibrosis
Nov. 15, 2017—To develop strategies for preventing radiation-induced lung fibrosis (scarring), Vanderbilt investigators are exploring the cell types and factors that contribute to the fibrotic response.
Pulmonary fibrosis culprits
Jun. 6, 2016—New findings identify isoketal-modified proteins as a previously unrecognized feature of pulmonary fibrosis and as a potential therapeutic target for this disease.
Targeting tumor “supply lines”
Dec. 18, 2013—A metabolic enzyme plays a crucial role in vascular development and may be a good target for cancer therapies.
Antioxidant genes keep stomach moving
Jun. 24, 2011—Antioxidant genes may be good targets for treating a stomach disorder that affects up to 40 percent of patients with diabetes.
